Company overview
TATAA Biocenter is a GLP-accredited CRO specializing in bioanalytical services for cell and gene therapies, including qPCR, dPCR, NGS, and proteomics. They provide biomarker discovery, assay validation, biodistribution, PK/PD analysis, and immune monitoring compliant with FDA, EMA, and GCLP standards. Their services support oligonucleotide drugs like mRNA, siRNA, ASOs, and CRISPR from preclinical to clinical stages.
TATAA Biocenter - Molecular bioanalytical CRO is listed in the NovaPharmaNews Supplier Hub as a CRO & Clinical Services, Diagnostics & Testing partner serving United States & Americas. Core focus areas include tataa biocenter, qpcr services, dpcr bioanalysis, ngs cro, cell gene therapy, glp accredited.
Industry categories: CRO & Clinical Services, Diagnostics & Testing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with TATAA Biocenter - Molecular bioanalytical CRO include Assay, Cro, Pcr — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://tataa.com
- Categories
- CRO & Clinical Services, Diagnostics & Testing
- Markets served
- United States & Americas
- Keywords
- tataa biocenter, qpcr services, dpcr bioanalysis, ngs cro, cell gene therapy, glp accredited, biomarker assays
Products & technologies
Therapeutic areas
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What bioanalytical technologies does TATAA Biocenter offer?
- TATAA Biocenter offers qPCR, dPCR, NGS, nucleic acid extraction, and quantitative proteomics for biomarker analysis, mutation detection, and immune profiling in cell and gene therapies.
- What regulatory accreditations does TATAA Biocenter hold?
- They are GLP-accredited, GCLP-compliant, ISO/IEC 17025:2017 certified, and meet FDA and EMA expectations for bioanalysis in drug development.
- What therapeutic areas and geographies does TATAA Biocenter serve?
- TATAA focuses on cell and gene therapies, RNA therapeutics, ASOs, and precision medicine, operating from a state-of-the-art facility in Gothenburg, Sweden, serving global biopharma clients.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
